1. Liu, Jun, Mi, Jinglin, Liu, Shiqian, Chen, Haiqiang, Jiang, Li. 2022. PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma. In FEBS open bio, 12, 2025-2041. doi:10.1002/2211-5463.13479. https://pubmed.ncbi.nlm.nih.gov/36062301/
2. Lv, Ying, Hu, Qian, Shi, Mingyang, Zhang, Aihua, Hu, Yong. 2020. The role of PSMB5 in sodium arsenite-induced oxidative stress in L-02 cells. In Cell stress & chaperones, 25, 533-540. doi:10.1007/s12192-020-01104-1. https://pubmed.ncbi.nlm.nih.gov/32301004/
3. Kohda, K, Matsuda, Y, Ishibashi, T, Tanaka, K, Kasahara, M. . Structural analysis and chromosomal localization of the mouse Psmb5 gene coding for the constitutively expressed beta-type proteasome subunit. In Immunogenetics, 47, 77-87. doi:. https://pubmed.ncbi.nlm.nih.gov/9382924/
4. Wang, Chih-Yang, Li, Chung-Yen, Hsu, Hui-Ping, Chen, Yi-Ling, Lai, Ming-Derg. 2017. PSMB5 plays a dual role in cancer development and immunosuppression. In American journal of cancer research, 7, 2103-2120. doi:. https://pubmed.ncbi.nlm.nih.gov/29218236/
5. Kong, Ha Eun, Lim, Junghwa, Linsalata, Alexander, Warren, Stephen T, Jin, Peng. 2022. Identification of PSMB5 as a genetic modifier of fragile X-associated tremor/ataxia syndrome. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2118124119. doi:10.1073/pnas.2118124119. https://pubmed.ncbi.nlm.nih.gov/35617426/
6. Lai, Guangrui, Sun, Ru, Wu, Jingjing, Zhang, Bijun, Zhao, Yanyan. 2017. 20-HETE regulated PSMB5 expression via TGF-β/Smad signaling pathway. In Prostaglandins & other lipid mediators, 134, 123-130. doi:10.1016/j.prostaglandins.2017.08.005. https://pubmed.ncbi.nlm.nih.gov/28807746/
智鼠故事 
